Cytokinetics eps

Author: eniu

August undefined, 2024

WebDiluted EPS (ttm)-4.33. Dividends Per Share. N/A. Dividend Yield. N/A. Ex-Dividend Date. N/A. ... Cytokinetics, a biotechnology company, had hoped that by focusing on improving the function of ... WebCytokinetics, Inc. operates as a biopharmaceutical company, which focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases.

Inspire Investing LLC Raises Stake in Cytokinetics, Incorporated ...

WebApr 9, 2024 · Cytokinetics (NASDAQ:CYTK – Get Rating) last issued its quarterly earnings results on Wednesday, March 1st.The biopharmaceutical company reported ($1.45) EPS for the quarter, missing analysts ... WebApr 10, 2024 · Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and … blue book old trucks

Cytokinetics EPS misses by $0.19, misses on revenue

WebCytokinetics Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View CYTK financial statements in full. ... Qtr. EPS Est.-1.21 Q4 2024: Qtr. Year Ago-0.36 Q4 ... WebApr 13, 2024 · During the same quarter in the previous year, the firm posted ($0.36) EPS. Research analysts predict that Cytokinetics, Incorporated will post -4.4 earnings per share for the current fiscal year. Insiders Place Their Bets. In other Cytokinetics news, CEO Robert I. Blum sold 12,500 shares of the company’s stock in a transaction on Tuesday ... Web18 hours ago · Price & EPS Surprise; 12 Month EPS; Broker Recommendations; Financials ... Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 04/03/23-4:00PM EST GlobeNewswire free image of pancakes

Cytokinetics, Incorporated (CYTK) Stock Price, News, Quote

Cytokinetics, Incorporated Common Stock (CYTK) Revenue EPS Nasdaq

WebApr 6, 2024 · CYTK Earnings Date 2024 Cytokinetics Earnings Forecast S&P 500 4,105.02 DOW 33,485.29 Biden To Unleash "Choke Point" Operation On America? (Ad) Bear market expert makes new prediction (Ad) JP Morgan analyst: Oil to hit $380 per barrel (Ad) Biden To Unleash "Choke Point" Operation On America? (Ad) Bear market expert … WebNov 3, 2024 · Cytokinetics (CYTK): Q3 GAAP EPS of -$0.95 misses by $0.19.Revenue of $5.4M misses by $0.58M.Cash, cash equivalents and investments totaled $668.9 million at September 30,... free image of old fashioned candle glowingWebCytokinetics eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per … free image of people

"WebFeb 24, 2024 · Cytokinetics press release (CYTK): Q4 GAAP EPS of -$0.36 beats by $0.51.Revenue of $55.6M (+727.4% Y/Y) beats by $50.04M.Cash, cash equivalents and … " - Cytokinetics eps

Cytokinetics eps

CYTK Stock Forecast, Price & News (Cytokinetics)

WebFeb 25, 2024 · Healthcare Cytokinetics EPS misses by $0.13, misses on revenue Feb. 25, 2024 4:19 PM ET Cytokinetics, Incorporated (CYTK) CYTK By: Gaurav Batavia, SA News Editor Cytokinetics (NASDAQ: CYTK):... WebFeb 24, 2024 · Cytokinetics press release (NASDAQ: CYTK): Q4 GAAP EPS of -$0.36 beats by $0.51. Revenue of $55.6M (+727.4% Y/Y) beats by $50.04M. Cash, cash equivalents and investments totaled $623.7 million...

Did you know?

WebJun 5, 2024 · Types of Cytokines. Cytokines are diverse and serve a number of functions in the body. They: Stimulate the production of blood cells. Aid in the development, …

WebApr 9, 2024 · Cytokinetics, Incorporated has a 12-month low of $32.96 and a 12-month high of $55.80. Cytokinetics (NASDAQ:CYTK – Get Rating) last announced its quarterly earnings data on Wednesday, March 1st ... WebFind the latest Revenue & EPS data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com. Cytokinetics, Incorporated Common Stock (CYTK) Revenue EPS Nasdaq Skip to main content

WebApr 5, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as … WebFeb 28, 2024 · February 28, 2024 — 08:40 am EST. Written by Zacks Equity Research for Zacks ->. Investors are always looking for stocks that are poised to beat at earnings season and Cytokinetics, Incorporated ...

WebFind the latest Revenue & EPS data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com.

WebFeb 28, 2024 · This suggests that analysts have very recently bumped up their estimates for CYTK, giving the stock a Zacks Earnings ESP of +3.19% heading into earnings season. … blue book on 2013 ford edgeWebFeb 24, 2024 · Cytokinetics (CYTK) delivered earnings and revenue surprises of 59.55% and 931.54%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? free image of pen and paperWebFeb 17, 2024 · This biopharmaceutical company is expected to post quarterly loss of $0.89 per share in its upcoming report, which represents a year-over-year change of -43.6%. Revenues are expected to be $4.84... free image of people walkingWebApr 9, 2024 · Cytokinetics, Incorporated has a 1 year low of $32.96 and a 1 year high of $55.80. Cytokinetics ( NASDAQ:CYTK – Get Rating) last released its quarterly earnings results on Wednesday, March 1st.... free image of popcornWebDECEMBER 23, 2004 VA DIRECTIVE 5383 7. g. Section 503 of the Supplemental Appropriations Act of 1987, Public Law 100-71, 101 Stat. 391, 468-471, codified at Title 5 … free image of pink flowersWebApr 10, 2024 · The company is expected to report EPS of $2.50, down 6.37% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $23.56 billion, up 0.59% from ... blue book on 2009 buick 2 seaterWebApr 6, 2024 · EPS-$4.25; Yield N/A; Dividend N/A; Ex-Dividend Date N/A; Short Interest 10.34M 03/15/23 % of Float Shorted 11.58%; Average Volume 992.07K; ... Cytokinetics, Inc. is a biopharmaceutical company ... blue book on 2017 ford f150